December 21, 2023 News by Steve Bryson, PhD New AI algorithm provides better MRI images of brain in MS: Study DeepSTI, a new artificial intelligence or AI-assisted MRI algorithm, can generate high-resolution, 3D images of the brain from only one head orientation. This new technology may allow clinicians to use fewer scans to visualize changes in the brain caused by neurological diseases, such as multiple sclerosis (MS), a study…
December 1, 2023 News by Andrea Lobo, PhD FDA clears BrainSpec’s tool to measure metabolites on brain scans The U.S. Food and Drug Administration (FDA) has cleared BrainSpec Core, a platform that performs non-invasive measurements of brain chemistry, for use in diagnosing some of the most common diseases that affect the brain, including multiple sclerosis (MS). Developed by BrainSpec, the platform uses magnetic resonance spectroscopy (MRS)…
November 27, 2023 News by Marisa Wexler, MS FDA clears AI tool for detecting disease activity on MRI scans Pixyl.Neuro, a next-generation software that uses artificial intelligence (AI) in analyzing MRI scans to help detect and monitor multiple sclerosis (MS) disease activity, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for clinical use. 510(k) clearance is required for medical devices used in the…
July 7, 2023 News by Andrea Lobo, PhD CPT code issued for MRI brain scan software by Icometrix Icometrix‘s quantification software for brain MRI scans has received a Current Procedural Terminology (CPT) III code, a temporary code for emerging technologies that should facilitate reimbursement. CPT codes, issued by the American Medical Association, are designed to identify procedures and services in healthcare plans. They are used in the…
March 15, 2023 News by Marisa Wexler, MS Analyzing MS brain scans could further research into COVID-19 Because people with multiple sclerosis (MS) usually undergo regular MRI scans to image their brains, their data could help researchers learn more the long-term effects of COVID-19 on brain tissue. Thatās the argument by a team of researchers in the paper, āMultiple sclerosis as a…
September 14, 2022 News by Lindsey Shapiro, PhD Inflammatory Brain Lesions Often Don’t Match Relapse Symptoms More than half of relapsing-remitting multiple sclerosis (RRMS) patients in a small study had active inflammatory brain lesions during a relapse, even when relapse symptoms occurred outside the brain, in areas including the spinal cord or optic nerve, researchers in Spain reported. Less than half of the patients with…
March 29, 2022 News by Hawken Miller Artist With MS Finds Beauty, Individuality in MRI Brain Scans Reviewing an MRI of oneās brain and seeing lesions on it is a frightening prospect for people with multiple sclerosis (MS). āThe lesions, the bright spots on a brain scan, that’s probably the last place in your body most of us want to see things. [It’s] such an important…
February 7, 2020 News by Marisa Wexler, MS Mayzent Approved in Europe as First Oral Treatment for Active Secondary Progressive MS The experimental BTK inhibitor SAR442168 showed an acceptable safety profile and met its primary endpoint ā a significant reduction in the number of new lesions visible on a brain imaging scan ā in a Phase 2 trial in people with multiple sclerosis (MS), study results show. SAR442168,…